晚期浆液性上皮性卵巢癌转移灶与卵巢癌标准化摄取值比值的预后意义
回顾性分析94例FIGO III、IV期浆液性上皮性卵巢癌患者的临床病理资料与术前18F-FDG PET/CT参数,评估转移灶代谢活动的预后价值。中位无进展生存期为18.5个月,57例(60.6%)复发;高SUVmeta/SUVovary是复发的独立危险因素(P=0.019,HR 2.321,95%CI 1.148-4.692),且高比值组无进展生存期显著更差(P=0.007)。术前SUVmeta/SUVovary与复发显著相关,对无进展生存期具有增量预后价值。
要点
- 高SUVmeta/SUVovary是晚期浆液性上皮性卵巢癌复发的独立危险因素(HR 2.321)。
- 高SUVmeta/SUVovary组无进展生存期显著差于低比值组(P=0.007)。
- 术前PET/CT测量的转移灶与卵巢癌摄取值比值可辅助预测复发。
核心结论
- 术前SUVmeta/SUVovary与复发显著相关,对晚期浆液性上皮性卵巢癌患者的无进展生存期具有增量预后价值。
研究设计与样本
- 回顾性分析94例FIGO III、IV期浆液性上皮性卵巢癌患者的临床病理资料与术前18F-FDG PET/CT参数。
- 评估参数包括卵巢癌最大标准化摄取值(SUVovary)、转移灶最大标准化摄取值(SUVmeta)及转移灶与卵巢癌标准化摄取值比值(SUVmeta/SUVovary)。
关键影像表现/征象
- 术前18F-FDG PET/CT测量卵巢癌及转移灶的代谢活动,计算SUVmeta/SUVovary比值。
诊断标准与关键数值
- 中位无进展生存期18.5个月(范围6-90个月),57例(60.6%)患者复发。
- 高龄(P=0.017,HR 1.036,95%CI 1.006-1.066)、术后残留病灶(P=0.024,HR 1.907,95%CI 1.087-3.346)和高SUVmeta/SUVovary(P=0.019,HR 2.321,95%CI 1.148-4.692)是复发的独立危险因素。
- 高SUVmeta/SUVovary组无进展生存期显著差于低SUVmeta/SUVovary组(P=0.007,log-rank检验)。
临床应用与阅片要点
- 术前PET/CT可测量卵巢癌及转移灶的18F-FDG摄取并计算SUVmeta/SUVovary,该比值与复发相关并具增量预后价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the prognostic value of metabolic activity of metastatic lesions measured by 18F-flurodeoxyglucose (18F-FDG) uptake on preoperative positron emission tomography/computed tomography (PET/CT) in patients with advanced serous epithelial ovarian cancer (EOC).
METHODS: Clinico-pathological variables and PET/CT parameters such as the maximum standardised uptake value of the ovarian cancer (SUVovary), metastatic lesions (SUVmeta), and the metastatic lesion-to-ovarian cancer standardised uptake value ratio (SUVmeta/SUVovary) were assessed in International Federation of Gynaecology and Obstetrics (FIGO) stage III, IV patients.
RESULTS: Clinico-pathological data were retrospectively reviewed for 94 eligible patients. The median progression-free survival (PFS) was 18.5 months (range, 6-90 months), and 57 (60.6%) patients experienced recurrence. Older age [P = 0.017, hazard ratio (HR) 1.036, 95% CI 1.006-1.066], residual disease after surgery (P = 0.024, HR 1.907, 95% CI 1.087-3.346), and high SUVmeta/SUVovary (P = 0.019, HR 2.321, 95% CI 1.148-4.692) were independent risk factors of recurrence. Patients with high SUVmeta/SUVovary showed a significantly worse PFS than those with low SUVmeta/SUVovary (P = 0.007, log-rank test).
CONCLUSIONS: Preoperative SUVmeta/SUVovary was significantly associated with recurrence and has an incremental prognostic value for PFS in patients with advanced serous EOC.
KEY POINTS: • The prognostic value of the metabolic activity of metastatic lesions was investigated. • SUVmeta/SUVovary was significantly associated with recurrence of serous EOC. • Preoperative SUVmeta/SUVovary can be a predicator of serous EOC recurrence.
引用
- Chung HH, Lee M, Kim HS, et al. Prognostic implication of the metastatic lesion-to-ovarian cancer standardised uptake value ratio in advanced serous epithelial ovarian cancer. Eur Radiol. 2017. PMID: 28593431. doi:10.1007/s00330-017-4883-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。